JP2022550828A5 - - Google Patents
Info
- Publication number
- JP2022550828A5 JP2022550828A5 JP2022520291A JP2022520291A JP2022550828A5 JP 2022550828 A5 JP2022550828 A5 JP 2022550828A5 JP 2022520291 A JP2022520291 A JP 2022520291A JP 2022520291 A JP2022520291 A JP 2022520291A JP 2022550828 A5 JP2022550828 A5 JP 2022550828A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- cabotegravir
- administered
- once
- intramuscular injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962908995P | 2019-10-01 | 2019-10-01 | |
| US201962908882P | 2019-10-01 | 2019-10-01 | |
| US62/908,882 | 2019-10-01 | ||
| US62/908,995 | 2019-10-01 | ||
| US202063037782P | 2020-06-11 | 2020-06-11 | |
| US63/037,782 | 2020-06-11 | ||
| US202063052214P | 2020-07-15 | 2020-07-15 | |
| US63/052,214 | 2020-07-15 | ||
| PCT/IB2020/059185 WO2021064618A1 (en) | 2019-10-01 | 2020-10-01 | Method for treating hiv with cabotegravir and rilpivirine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022550828A JP2022550828A (ja) | 2022-12-05 |
| JP2022550828A5 true JP2022550828A5 (enExample) | 2023-10-12 |
| JP7791083B2 JP7791083B2 (ja) | 2025-12-23 |
Family
ID=72826936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520291A Active JP7791083B2 (ja) | 2019-10-01 | 2020-10-01 | カボテグラビルおよびリルピビリンでｈｉｖを治療するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20220347174A1 (enExample) |
| EP (1) | EP4037661A1 (enExample) |
| JP (1) | JP7791083B2 (enExample) |
| KR (1) | KR20220074880A (enExample) |
| CN (2) | CN118416069A (enExample) |
| AU (1) | AU2020358156B2 (enExample) |
| CA (1) | CA3155587A1 (enExample) |
| CL (1) | CL2022000790A1 (enExample) |
| IL (1) | IL290716A (enExample) |
| MX (1) | MX2022003945A (enExample) |
| WO (1) | WO2021064618A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210033492A (ko) | 2018-07-16 | 2021-03-26 | 길리애드 사이언시즈, 인코포레이티드 | Hiv의 치료를 위한 캡시드 억제제 |
| WO2023222755A1 (en) * | 2022-05-17 | 2023-11-23 | Janssen Sciences Ireland Unlimited Company | Treatment or prevention of hiv infection |
| WO2023222754A1 (en) * | 2022-05-17 | 2023-11-23 | Janssen Sciences Ireland Unlimited Company | Rilpivirine for use in the treatment or prevention of hiv infection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010299959B2 (en) * | 2009-09-22 | 2016-07-21 | Tibotec Pharmaceuticals | Treatment and prevention of HIV infection |
| US11564921B2 (en) * | 2017-07-21 | 2023-01-31 | Viiv Healthcare Company | Regimens for treating HIV infections and AIDS |
| CN109568328A (zh) * | 2017-09-29 | 2019-04-05 | 重庆药友制药有限责任公司 | 一种用于预防和治疗hiv感染的药物组合物 |
| BR112021025655A2 (pt) * | 2019-06-19 | 2022-02-01 | Viiv Healthcare Uk No 5 Ltd | Inibidores da replicação do vírus da imunodeficiência humana |
-
2020
- 2020-10-01 MX MX2022003945A patent/MX2022003945A/es unknown
- 2020-10-01 AU AU2020358156A patent/AU2020358156B2/en active Active
- 2020-10-01 JP JP2022520291A patent/JP7791083B2/ja active Active
- 2020-10-01 CN CN202410349180.8A patent/CN118416069A/zh active Pending
- 2020-10-01 WO PCT/IB2020/059185 patent/WO2021064618A1/en not_active Ceased
- 2020-10-01 US US17/763,076 patent/US20220347174A1/en not_active Abandoned
- 2020-10-01 KR KR1020227010390A patent/KR20220074880A/ko active Pending
- 2020-10-01 CN CN202080069721.1A patent/CN114502166A/zh active Pending
- 2020-10-01 EP EP20789687.9A patent/EP4037661A1/en active Pending
- 2020-10-01 CA CA3155587A patent/CA3155587A1/en active Pending
-
2022
- 2022-02-17 IL IL290716A patent/IL290716A/en unknown
- 2022-03-30 CL CL2022000790A patent/CL2022000790A1/es unknown
-
2025
- 2025-06-04 US US19/227,593 patent/US20250302829A1/en active Pending
- 2025-06-04 US US19/227,609 patent/US20250302830A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018184417A5 (enExample) | ||
| JP2025020134A5 (enExample) | ||
| JP2022550828A5 (enExample) | ||
| JP2015187125A5 (enExample) | ||
| JP2023541430A5 (enExample) | ||
| JP2016185995A5 (enExample) | ||
| JP2022062170A5 (enExample) | ||
| JP2017160178A5 (enExample) | ||
| JP2018507243A5 (enExample) | ||
| JP2022527398A5 (enExample) | ||
| JP2022523726A5 (enExample) | ||
| FI3493812T3 (fi) | Imetelstaatin ja venetoklaksin yhdistelmiä akuutin myelooisen leukemian hoitoa varten | |
| JP2021509395A5 (enExample) | ||
| JP2024507810A5 (enExample) | ||
| JP2022531251A5 (enExample) | ||
| JP2022508513A5 (enExample) | ||
| JP2019511506A5 (enExample) | ||
| JP2022549621A5 (enExample) | ||
| JP2022551691A5 (enExample) | ||
| JP2019534251A5 (enExample) | ||
| JP2024517085A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2021004249A5 (enExample) | ||
| JP2025508098A5 (enExample) | ||
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. |